In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases.

Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the following plans for Domestic and International shipping:

Register now – July 8, 2025: PACE / State of FL - This webinar will discuss a range of critical topics essential for laboratory billing, coding, and compliance. Key areas of focus will include understanding and navigating National Correct Coding Initiative (NCCI) edits, reviewing newly released CPT codes, exploring important updates from Medicare Manuals, and discussing the process for submitting LCD Reconsideration Requests. Additionally, we will share insights into the latest priorities outlined in the OIG Workplan, helping organizations stay informed and aligned with federal expectations.

John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.

Fergus Couch, Ph.D., chair of Mayo Clinic’s Division of Experimental Pathology and Laboratory Medicine, led a team that recently published new National Institutes of Health and U.S. Food and Drug Administration-approved guidelines for the interpretation of variants in the ataxia telangiectasia mutated (ATM) cancer gene. Inherited mutations in ATM have been shown to increase the risk of breast, pancreatic, and prostate cancers. Now published by the American Journal of Human Genetics and available for widespread use, Dr. Couch says the guidelines can help clinicians around the world apply the same consistent method of classification to ATM variants.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews John Sherbeck, M.D., Laboratory Medical Director of Trinity Health IHA Medical Group, about how to plan your time at medical conferences and briefly discusses this year’s takeaways from AABB’s national conference.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent outbreaks in vaccine-preventable diseases.

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, recently shared with the Advisory Board his insight into the potential that digital pathology and out-of-lab testing can bring into the laboratory space.

JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified, wondered if she was dying. Luckily, she had a guardian angel by her side: her mother, a retired nurse practitioner, who took her to Mayo Clinic, where the clinical experience and expertise of neurologist Andrew McKeon, M.B., B.Ch., M.D., helped give her a diagnosis and hope for a journey back to health.

This month’s microlearning shares the Elicit – Provide – Elicit framework for exchanging information in a collaborative way.

This page lists updates posted to Mayo Clinic Labs during the month of October.

Due to the Thanksgiving holiday (recognized on Thursday, Nov. 28), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

PACE / State of FLThis webinar will describe substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring. The advantages and challenges of using oral fluid will be discussed along with how to correctly interpret oral fluid drug testing results.

Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the right molecular tests for patients, the impact of genetic testing on cancer diagnosis and treatment, and how Mayo Clinic Laboratories is helping physicians make informed decisions for the best patient outcomes.

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton for the second part of their discussion on minimizing visible impact to the customer when there are bumps in the road.